Search

You searched for "radiological"

615 results found

PIRADS-3 lesions and clinically significant prostate cancer – what are we missing?

5 December 2022 | | URO - Urologic Oncology
The use of pre-biopsy MRI has definitely enhanced our decision making in managing patients with suspected prostate cancer (PCa). There is still uncertainty around the outcomes for patients with PIRADS-3 lesions, with a small but definite risk of missing clinically...

The Royal Marsden: Uro-Oncology Study Day

23 June 2025
This study day will provide a greater understanding of urological cancers.

An overview of daytime wetting in children

1 January 2017 | | URO - Functional / Reconstructive Urology, URO - Paediatric Urology
It is estimated that daytime wetting affects one in seventy-five children over the age of five years [1]. Daytime wetting is commoner in younger children (1 in 7 aged 4.5 years, 1 in 20 aged 9.5 years) [1]. Many younger...

Demanding cases or nightmares in uro-oncology? Jan/Feb 2023

6 January 2023 | | URO - Urologic Oncology
Radical surgical treatment of prostate cancer has become minimally invasive owing to robotic assisted laparoscopic technology [1]. Patients who undergo robotic assisted radical prostatectomy (RARP) often have lower risk of morbidity compared to an open approach. However, patients with a...

Visual-estimation (cognitive), image-fusion (software) and in-bore targeted prostate biopsy: is there an optimal approach?

3 March 2021 | | URO - Urologic Oncology, URO - Technology
The diagnostic superiority of multiparametric magnetic resonance imaging (mpMRI) prior to targeted and systematic prostate biopsy over systematic transrectal ultrasound-guided (TRUS) biopsy alone in the detection of clinically significant prostate cancer (csPCa) has been proven by multiple level 1 studies...

Technology for remote working and COVID-19 resources

2 April 2020 |
The COVID-19 pandemic has altered every aspect of how we live, and how healthcare needs to be provided for the welfare of patients and staff. I thought I would try to summarise a few potential technology tools that could be...

BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis

6 May 2020 | Contracts & Distributors
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...

IRCAD France: Laparoscopic Urological Surgery Intensive Course (Oct 24)

7 October 2024 -11 October 2024
Course objectives To provide the basic knowledge required for clinical applications To describe all the basic principles (instruments, materials, anesthesia equipment) and present the most widely used basic laparoscopic urological techniques To provide hands-on training sessions to learn or improve performance of basic technical tasks in laparoscopic urological surgery To describe results and potential complications of laparoscopic procedures

IRCAD France: Laparoscopic Urological Surgery Intensive Course (Dec 24)

2 December 2024 -6 December 2024
Course objectives To provide the basic knowledge required for clinical applications To describe all the basic principles (instruments, materials, anesthesia equipment) and present the most widely used basic laparoscopic urological techniques To provide hands-on training sessions to learn or improve performance of basic technical tasks in laparoscopic urological surgery To describe results and potential complications of laparoscopic procedures

18th GURS Masterclass 2024

6 November 2024 -8 November 2024
Inclusive Care for All Patients Requiring Reconstructive Urological Surgery The 18th GURS Masterclass will focus on inclusive care for patients needing reconstructive urological surgery. This online conference will be streamed live from UCH Westmoreland Street Hospital, London, from November 6th to 8th, 8:00 to 18:00 GMT. Faculty members will present and engage in discussions from our Film Studio.

The role of PET-CT imaging in prostate cancer

4 October 2021 | | URO - Urologic Oncology
Prostate cancer (PCa) is the second most common cancer in the UK, with 43,000 cases in 2017-18 [1,2]. Accurate primary staging and the detection of suspected recurrence following treatment is vital for directing management and predicting prognosis. This has conventionally...

Understanding Stauffer’s syndrome

1 May 2018 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology, URO - Paediatric Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Who was Stauffer and what is Stauffer’s syndrome? Maurice Stauffer (1915-1994) was a gastroenterologist at the Mayo Clinic in Rochester, United States, and in 1961 first characterised the non-metastatic, paraneoplastic effects of renal cell carcinoma (RCC) on liver size and...